Skip to content
GenoLensGenoLens

SCUBE3

Chr 6p21.3

signal peptide, CUB domain and EGF like domain containing 3

Aliases:
FLJ34743
MANE:
ENST00000274938.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Limb disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Clefting

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2

    0.78
  • Abnormality of the dentition

    0.52
  • Abnormal facial shape

    0.52
  • Short stature

    0.52
  • Abnormality of the skeletal system

    0.52
  • short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies

    0.51
  • systemic lupus erythematosus

    0.35
  • hypothyroidism

    0.29
  • placenta praevia

    0.28
  • type 1 diabetes mellitus

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Signal peptide, CUB and EGF-like domain-containing protein 3

Is a positive regulator of the BMP signaling pathway, required for proper chondrogenesis, osteogenesis and skeletal development. It acts as a coreceptor for BMP ligands, particularly BMP2 and BMP4, facilitating their interactions with BMP type I receptors (PubMed:33308444). It is required for ligand-induced recruitment of BMP receptors to lipid rafts (By similarity). Binds to TGFBR2 and activates TGFB signaling. In lung cancer cells, could serve as an endogenous autocrine and paracrine ligand of TGFBR2, which could regulate TGFBR2 signaling and hence modulate epithelial-mesenchymal transition and cancer progression

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.